COVID-19 continues to wage war despite the fact that it has less and less incidence
The intranasal vaccine has great advantages
Although the COVID-19 seems ready for sentencing, there are still cases and society must slowly prepare for what is to come in the fall.
The passing of the years has allowed the human being to know now more than ever about the Coronavirus, but also about all viruses in general. For this reason, the CSIC has confirmed that At the end of 2023, the first intranasal vaccine will arrive. The research and tests on the disease have begun to bear fruit and fortunately this vaccine, which will be infinitely less intrusive than the previous ones, can be launched in a year.
The director of Coronavirus Laboratory of the National Center for BiotechnologyLuis Enjuanes has been in charge of giving the date and he explained that “It will not be able to have a practical use until the end of next year” and regarding the delay in its launch he explains that “We are late but we can deal with the variants”.
The EU could authorize a vaccine against COVID-19 from South Korea
The virologist has assured that the new aspects against COVID-19 they will be much milder and will be experienced this fall in a much more devious way. Thus, the objective is to care for vulnerable people while the rest of the population can surely lead a normal life.